ClinicalTrials.gg
TerminatedNCT04039178Updated Feb 11, 2021

Efficacy of EMF BCI Based Device on Acute Stroke

An interventional study of BQ and Sham in Acute Stroke, sponsored by BrainQ Technologies Ltd.. Terminated at 1 site in India. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-02-11.

Sponsored by BrainQ Technologies Ltd. · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
The study was terminated at the interim point due to the covid-19 pandemic, which did not allow completing full recruitment in relevant timelines

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Sep 2018, registered Jul 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 70 studies in Stroke with a site in India — 6 open to participants now, 9 under way, 4 of them phase 3. Stroke · India.

Enrollment
56th of 63
28 · median 317
Started
2018
with 3 others
No phase
19 of 70
2 open now
Registered
52nd of 70
by date

Among the 70 studies in Stroke with a site in India, this one is the 56th largest by enrollment of the 63 interventional ones that give a count, is one of 4 that started in 2018, is one of 19 with no phase, and was the 52nd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

6 of the 70 studies in Stroke with a site in India are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Stroke with a site in India, or all of them as a file.
02

Study summary

The study tests the efficacy of a non-invasive device with low intensity electromagnetic field dedicated treatment to enhance the recovery of stroke patients impaired hand motor function

Read the detailed description

The study investigates the effect of BCI based stimulation device on upper limb motor function of acute stroke patients.

The BQ device (BrainQ Technologies Ltd., Israel), a Brain Computer Interface based stimulation device, uses machine learning tools to identify high resolution spectral patterns associated with motor functions in EEG measurements of healthy/non healthy subjects. These patterns are then translated into a tailored frequency dependent low intensity, non-invasive electro-magnetic treatment protocol.

03

Conditions studied

  • Acute Stroke

Browse trials for

Keywords

  • BCI
  • BQ
  • motor function
  • acute stroke
  • EMF
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of 1st ever ischemic stroke confirmed by imaging or 1st recurrent ischemic stroke with no previous neurological impairment in the same limb before current stroke happened
  2. 72h to 15 days from stroke onset or 21 days from stroke onset in case the patient was still unstable at day 15 from stroke onset).
  3. Medically stable patients
  4. Age: > 18, \<80 years, and independent in their daily activities before the stroke
  5. Right dominant hand
  6. FM >10, \<45 of upper tested limb.
  7. Able to sit in a chair for 70 consecutive minutes and follow three verbal instructions:

    • Bring your healthy arm to the level of your shoulder
    • Pick up this pen with your healthy hand.
    • Put your healthy hand on your waist
  8. Able to understand the information provided and provide

Exclusion criteria

Exclusion Criteria

  1. for performing MRI scanning
  2. History of recent epileptic seizures or epilepsy and/or currently taking medication that are known to lower the seizure threshold
  3. Patients with an acute problem such as active infection at the time of recruitment for research
  4. Previous disease of the central nervous system
  5. Damage to the joints, bones and muscles causing restriction of movement of the upper limb being tested
  6. Patients known to suffer from some peripheral nerve damage of the upper limb that being tested
  7. Pregnant women and women who have the ability to become pregnant unless they are on an acceptable method of during the study.
  8. Alcoholism or drug addiction as defined by within last 5 years
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Active comparator
    Treatment group

    Real BQ treatment, 40 treatments including 20 minutes of device guided functional motor tasks.

    Device: BQ

  • Sham comparator
    Control group

    Sham BQ treatment, (zero intensity) 40 treatments including 20 minutes of device guided functional motor tasks.

    Device: Sham

Interventions

  • DeviceBQ

    The BQ device (BrainQ Technologies Ltd., Israel), a Brain Computer Interface based stimulation device, uses machine learning tools to identify high resolution spectral patterns associated with motor functions in EEG measurements of healthy/non healthy subjects. These patterns are then translated into a tailored frequency dependent low intensity, non-invasive electro-magnetic treatment protocol.

    Also known as: Formerly VLIFE

  • DeviceSham

    Sham BQ device

06

What researchers measure

Primary outcomes

  1. Fugl Meyer Assessment of Upper Extremity (FMA-UE)

    FMA score of upper limb, range between 0 to 66 (higher the better)

    Time frame: Two months

Secondary outcomes

  1. ARAT

    Action Research Arm test

    Time frame: two months

  2. BBT

    Box and Blocks test

    Time frame: two months

  3. TMT

    Trail making test

    Time frame: two months

  4. NIHSS

    The national institutes of health stroke scale, a 0 to 42 scale, the higher the worse.

    Time frame: two months

  5. Promis 10

    The PROMIS Global Health short form, 10 questions questionnaire, calculated through a look up t-score table

    Time frame: two months

  6. MoCA

    Montreal cognitive assessment

    Time frame: two months

  7. mRs

    modified Rankin scale, a 0 to 6 scale, the higher the worse

    Time frame: two months

  8. MRI-DTI

    magnetic resonance imaging, diffusion tensor imaging

    Time frame: two months

  9. brain recovery biomarkers

    UCH-L1, and GFAP

    Time frame: two months

07

Study locations

1 site
  • BLK super specialty hospital
    New Delhi, India
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2018 to primary completion in Mar 2020, 18 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2019
First posted
Jul 31, 2019
StartActual
Sep 4, 2018
Primary completionActual
Mar 21, 2020
CompletionActual
Mar 21, 2020
Last update
Feb 11, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04039178
Lead sponsor
BrainQ Technologies Ltd.
Responsible party
Sponsor
First posted
Jul 31, 2019
Start date
Sep 4, 2018
Primary completion
Mar 21, 2020
Completion
Mar 21, 2020
Last update
Feb 11, 2021

Study contacts

Dharam P Pandey, PhD
principal investigator · BLK hospital , New Delhi , India

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion